Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside TNL Travel notches 101 Q1 2026 EPS beat but shares fall 226 on weak investor reaction Is US Gold USAU stock reacting to risk factors Q1 2026 Below Expectations Align ALGN Stock Is It Forming a Reversal Align logs 85 EPS beat on solid Invisalign sales XPO XPO notches 134 percent Q4 2025 EPS beat even as shares dip slightly in todays trading ETHMW Dynamix latest quarterly earnings prompt investor questions about future growth drivers and operational priorities